ASCP Applauds CDC for Variant Identification Efforts

ASCP wrote the Centers for Disease Control and Prevention (CDC) to thank the agency for its leadership in identifying and tracking coronavirus variants. In its letter, ASCP called out the CDC’s Advanced Molecular Detection (AMD) program for praise. ASCP noted that “vigilant monitoring for SARS-CoV-2 variants is important to an accurate understanding of the potential for reinfection by this virus as well as infection following vaccination (ie, real world vaccine efficacy). Data on the presence of SARS-CoV-2 variants is critical to understanding enhanced such issues as virus transmissibility, potentially enhanced virulence, resistance to monoclonal antibody and convalescent plasma therapies, and vaccine coverage.”

To read more articles from this issue of ePolicy, click here. To learn more about ePolicy News and access past newsletters and articles, click here.

For more information regarding ASCP's advocacy initiatives and policy positions, please contact ASCP's Center for Public Policy at (202) 408-1110.

ASCP ePolicy News is supported by an unrestricted grant from Hologic.